270 related articles for article (PubMed ID: 27890253)
1. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
Ning Y
Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
[TBL] [Abstract][Full Text] [Related]
2. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
[TBL] [Abstract][Full Text] [Related]
3. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
Reader JC; Leng Q; Rassool FV; Ning Y
Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
[TBL] [Abstract][Full Text] [Related]
4. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
5. The role of Nup98 in transcription regulation in healthy and diseased cells.
Franks TM; Hetzer MW
Trends Cell Biol; 2013 Mar; 23(3):112-7. PubMed ID: 23246429
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
[TBL] [Abstract][Full Text] [Related]
7. The role of NUP98 gene fusions in hematologic malignancy.
Slape C; Aplan PD
Leuk Lymphoma; 2004 Jul; 45(7):1341-50. PubMed ID: 15359631
[TBL] [Abstract][Full Text] [Related]
8. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
[TBL] [Abstract][Full Text] [Related]
9. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).
Taketani T; Taki T; Shibuya N; Kikuchi A; Hanada R; Hayashi Y
Cancer Res; 2002 Aug; 62(16):4571-4. PubMed ID: 12183408
[TBL] [Abstract][Full Text] [Related]
10. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
Nakamura T
Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
[TBL] [Abstract][Full Text] [Related]
11. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
12. NUP98 gene fusions in hematologic malignancies.
Lam DH; Aplan PD
Leukemia; 2001 Nov; 15(11):1689-95. PubMed ID: 11681408
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
14. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract][Full Text] [Related]
15. Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.
Gu BW; Wang Q; Wang JM; Xue YQ; Fang J; Wong KF; Chen B; Shi ZZ; Shi JY; Bai XT; Wu DH; Chen Z; Chen SJ
Leukemia; 2003 Sep; 17(9):1858-64. PubMed ID: 12970787
[TBL] [Abstract][Full Text] [Related]
16. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
[TBL] [Abstract][Full Text] [Related]
17. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
Gough SM; Slape CI; Aplan PD
Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
[TBL] [Abstract][Full Text] [Related]
18. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract][Full Text] [Related]
19. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).
Fujino T; Suzuki A; Ito Y; Ohyashiki K; Hatano Y; Miura I; Nakamura T
Blood; 2002 Feb; 99(4):1428-33. PubMed ID: 11830496
[TBL] [Abstract][Full Text] [Related]
20. Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9.
Aoki T; Miyamoto T; Yoshida S; Yamamoto A; Yamauchi T; Yoshimoto G; Mori Y; Kamezaki K; Iwasaki H; Takenaka K; Harada N; Nagafuji K; Teshima T; Akashi K
Int J Hematol; 2008 Dec; 88(5):571-574. PubMed ID: 19005624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]